Page 196 - ESHRE2019

P-047 Sperm DFI changes cytokines influences in fallopian tube using PCR array
R. Mohammadi1, S.O. Mousavi2, M. Sabbaghian3, S. Aghajanpour1, Z. Zandieh4, T. Maadani1, R. Aflatoonian1
1Royan institute for Reproductive Biomedicine., Department of Endocrinology and Female infertility- Reproductive Biomedicine Research Center, Tehran, Iran
2Faculty of Advanced Science and Technology- Tehran Medical Sciences- Islamic Azad University, Department of Genetics, Tehran, Iran
3Royan institute for Reproductive Biomedicine, Department of Andrology- Reproductive Biomedicine Research Center, Tehran, Iran
4Iran University of Medical sciences, Department of Anatomical science, Tehran, Iran
P-048 AZFc-gr/gr Partial Deletion and Related DAZ/CDY1 Copy Number Change is Associated with Azoospermia in Iranian Men
Z. Samiei1,2, M.A. Sadighi Gilani3, M.R. Zamanian1
1Reproductive Biomedicine Research Center- Royan Institute for Reproductive Biomedicine- ACECR, Department of Genetics, Tehran, Iran
2University of Science and Culture- ACECR, Faculty of Basic Sciences and Advanced Technologies in Biology, Tehran, Iran
3Reproductive Biomedicine Research Center- Royan Institute for Reproductive Biomedicine- ACECR, Department of Andrology, Tehran, Iran
P-049 Oxidation-reduction potential levels are not influenced by the presence of leukocytospermia
H. Elbardisi1, A. Majzoub1, K. AlRumaihi1, K. AlKubaisi1, S. AlSaid1, A. Agarwal2, R. Henkel3, M. Arafa1 1Hamad Medical Corporation, Urology, Doha, Qatar
2Cleveland Clinic, American Center for Reproductive Medicine, Cleveland- Ohio, U.S.A.
3Department of Medical Bioscience, University of the Western Cape, Bellville, South Africa
P-050 The use of phospholipase C zeta (PLCζ) analysis to identify candidates for artificial oocyte activation (AOA): a series of clinical pregnancies and proposed management algorithm
X. Meng1, P. Melo2, C. Jones1, C. Ross3, G. Mounce1, K. Turner1,3, T. Child1,3, K. Coward1
1University of Oxford, Nuffield Department of Women’s and Reproductive Health, Oxford, United Kingdom 2Oxford University Hospitals NHS Foundation Trust, The Women’s Centre, Oxford, United Kingdom 3Oxford Fertility, Nuffield Department of Women’s and Reproductive Health, Oxford, United Kingdom
P-051 Clinical outcome of ICSI cycles in a series of 112 patients with severe asthenozoospermia and ultrastructural flagellar defects: a 17-year experience
V. Mitchell1,2, A.L. Barbotin1,2, A. Loyens3, C. Decanter2,4, G. Robin2,4, N. Ramdane5, N. Rives6,7 1Lille University Hospital, Biology of Reproduction, Lille, France
2Lille University, EA 4308 “Gametogenesis and Gamete Quality”, Lille, France
3Inserm, Umr-s 1172, Lille, France
4Lille University Hospital, Endocrine Gynaecology and Reproductive Medicine, Lille, France 5Lille University Hospital, Biostatistics, Lille, France
6Rouen University Hospital, Biology of Reproduction Unit, Rouen, France
7Rouen University, EA4308: “Gametogenesis and Gamete Quality”, Rouen, France
196